肿瘤负荷可预测多灶性肝内胆管癌根治性切除后的结局
本研究基于国际多机构数据库,纳入1502例因肝内胆管癌(ICC)接受 upfront 根治性肝切除的患者,其中208例(13.8%)为多灶性ICC。多变量Cox回归显示肿瘤负荷评分(TBS)等为独立预后因素,RCS分析确定TBS 7.0为最佳截断值。低TBS(<7.0)多灶性ICC患者3年OS与单灶AJCC II/III期相当,而高TBS(≥7.0)者预后最差。
要点
- 多灶性ICC占根治性肝切除患者的13.8%,TBS是独立预后因素(HR 1.09)。
- TBS 7.0为最佳截断值,低TBS多灶性ICC的3年OS与单灶II/III期相当。
- 高TBS多灶性ICC预后最差,3年OS仅17.8%,需谨慎选择手术。
核心结论
- 高TBS多灶性ICC预后差,而低TBS多灶性ICC生存与单灶ICC相当,强调按肿瘤负荷分层指导手术决策。
研究设计与样本
- 国际多机构数据库回顾性研究,纳入1502例接受upfront根治性肝切除的ICC患者,其中208例(13.8%)为多灶性ICC。
主要发现
- 多灶性ICC中独立预后因素包括TBS(HR 1.09)、ASA分级>II(HR 1.48)、肝硬化(HR 2.05)、periductal infiltrating/mass forming plus periductal infiltrating形态亚型(HR 1.58)和接受辅助化疗(HR 0.59)。
- RCS分析确定TBS 7.0为最佳截断值。
- 3年OS:stage I且单灶67.1%,stage II/III且单灶43.2%,低TBS多灶43.4%,高TBS多灶17.8%(P < 0.001)。
关键数值与推荐
- TBS最佳截断值为7.0。
- 低TBS(<7.0)多灶性ICC的3年OS与单灶AJCC II/III期相当。
- 高TBS(≥7.0)多灶性ICC的3年OS为17.8%。
临床怎么用
- 对多灶性ICC患者术前计算TBS,低TBS(<7.0)者可考虑根治性切除,高TBS(≥7.0)者需权衡手术获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liver resection for multifocal intrahepatic cholangiocarcinoma (ICC) remains controversial due to a poor prognosis, driven by aggressive tumour biology. The aim of this study was to stratify multifocal ICC patients to identify those who are likely to benefit from resection. METHODS: Patients who underwent upfront curative-intent hepatectomy for ICC were identified from an international multi-institutional database. Among patients with multifocal tumours, overall survival (OS) was analysed using multivariable Cox regression to identify prognostic factors. Tumour burden score (TBS) was used for stratification of multifocal ICC, with the optimal cut-off determined via restricted cubic spline (RCS) analysis. RESULTS: Of 1502 patients, 208 (13.8%) had multifocal ICC. Among them, independent predictors of prognosis included TBS (HR 1.09), ASA grade >II (HR 1.48), cirrhosis (HR 2.05), periductal infiltrating/mass forming plus periductal infiltrating morphological subtype (HR 1.58), and receipt of adjuvant chemotherapy (HR 0.59). RCS analysis identified a TBS of 7.0 as the optimal cut-off. Notably, multifocal ICC patients with a low TBS (<7.0) demonstrated comparable 3-year OS to solitary ICC patients with AJCC stage II/III. In contrast, patients with a high TBS (≥7.0) and multifocal ICC exhibited the worst prognosis (3-year OS: stage I and solitary 67.1%, stage II/III and solitary 43.2%, low TBS and multifocal 43.4%, and high TBS and multifocal 17.8% (P < 0.001)). CONCLUSION: Whereas patients with high-TBS multifocal ICC had a poor prognosis, individuals with low-TBS multifocal ICC demonstrated survival outcomes comparable to solitary ICC patients. These findings emphasize the importance of stratifying patients by tumour burden to guide surgical decision-making and optimize treatment strategies for multifocal ICC.
引用
- Kawashima J, Akabane M, Khalil M, et al. Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma. Br J Surg. 2025. PMID: 40156894. doi:10.1093/bjs/znaf050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。